Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10550099 Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors

Patent 10550099 was granted and assigned to FORMA Therapeutics on February, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 11 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 11 Dec, 2023
Edits made to:
Article (+217 characters)
Article

Patent abstract

The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula:

Edits on 4 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 4 Oct, 2023
Edits made to:
Infobox (+10 properties)
Infobox
Patent Inventor Names
Ann-Marie Campbell0
Anna Ericsson0
David R. Lancia, Jr.0
Gary Gustafson0
Jian Lin0
Justin Andrew Caravella0
R. Bruce Diebold0
Susan Ashwell0
Wei Lu0
Zhongguo Wang0
Edits on 24 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 24 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
FORMA Therapeutics
FORMA Therapeutics
0
Current Assignee
FORMA Therapeutics
FORMA Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
105500990
Date of Patent
February 4, 2020
0
Patent Application Number
162903280
Date Filed
March 1, 2019
0
Patent Citations
‌
US Patent 10005734 Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
0
‌
US Patent 10253015 Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
0
‌
US Patent 10266495 Phenyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
0
‌
US Patent 10280150 Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors
0
‌
US Patent 10294206 Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
0
Patent Citations Received
‌
US Patent 10807976 Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors
0
‌
US Patent 10889567 Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
0
‌
US Patent 11498913 Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
0
Patent Primary Examiner
‌
Michael Barker
0
Edits on 1 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 1 Apr, 2023
Edits on 29 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 29 Mar, 2023
Edits on 16 Nov, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 16 Nov, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11498913 Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
0
Edits on 24 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Sep, 2022
Edits on 9 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 9 Feb, 2022
Edits on 7 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Feb, 2022
Edits on 1 Feb, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 1 Feb, 2022
Edits made to:
Infobox (+14 properties)
‌

 US Patent 10550099 Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors

Infobox
Is a
Patent
Patent
Patent applicant
FORMA Therapeutics
FORMA Therapeutics
Current assignee
FORMA Therapeutics
FORMA Therapeutics
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10550099
Date of patent
February 4, 2020
Patent application number
16290328
Date Filed
March 1, 2019
Patent citations
‌
US Patent 10005734 Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
‌
US Patent 10253015 Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
‌
US Patent 10266495 Phenyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
‌
US Patent 10280150 Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors
‌
US Patent 10294206 Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors
Patent primary examiner
‌
Michael Barker

Find more entities like US Patent 10550099 Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo